Outcome of Early Onset Systemic Lupus Erythmatosus - A Tertiary Care Study

Iffat Rafique; Yousaf  Jamal; Mohsin  Saif; Nuzhat  Rafeeq; Sana  Ikram; Adnan  Zaman

doi:10.51253/pafmj.v75iSUPPL-2.12343

Authors

Iffat Rafique Department of Medicine, Combined Military Hospital, Khairan/National University of Medical Sciences (NUMS) Pakistan
Yousaf Jamal Department of Medicine, Combined Military Hospital, Khairan/National University of Medical Sciences (NUMS) Pakistan
Mohsin Saif Department of Medicine, Combined Military Hospital, Khairan/National University of Medical Sciences (NUMS) Pakistan
Nuzhat Rafeeq Department of Radiology, Combined Military Hospital, Khairan/National University of Medical Sciences (NUMS) Pakistan
Sana Ikram Department of Medicine, Combined Military Hospital, Khairan/National University of Medical Sciences (NUMS) Pakistan
Adnan Zaman Department of Medicine, Combined Military Hospital, Khairan/National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v75iSUPPL-2.12343

Keywords:

Arthralgia, Early, lupus, Onset, Outcome.

Abstract

Objective: To evaluate the outcome of early onset systemic lupus erythematosus at tertiary care centre.

Study Design: A cross sectional study.

Place and Duration of Study: Combined Military Hospital, Kharian Pakistan, from Feb 2021 to Jan 2024.

Methodology: Total 77 female patients both indoor and outdoor were included. Patients <16 years (juvenile onset) and >50 years (late onset lupus) were excluded. Clinical manifestations as fever, arthralgia, mucocutaneous lesions, malar rash, neuropsychiatric illness, and anaemias were observed on initial presentation. Outcome has been finalised by SPSS version 22. p-value of 0.05 or less was significant.

Results: Total 77 individuals, all were women (100%), including 64(83.1%) housewives, and 13(16.9%) working ladies. Mean age of patients was 31.86%(±7.9 SD) between 18 to 48 years. Photosensitivity is observed in 64(83.1%) patients. Complications have been noticed in 46(59.8%) patients. 4(5.2 %) died of lupus nephritis. Flare of lupus seen in 24(31.2%) patients. Lupus cerebritis in 11(14.3%), pericarditis in 7(9.1%), and haemolytic anaemia in 4(5.2%) patients. 31(40.2%) patients went in remission.

Conclusion: Early onset Systemic lupus Erythematosus has an aggressive clinical course. A substantial improvement in management, may help to improve the outcome and delay life-threatening complications.

Downloads

References

Lalani S, Pope J, Leon F D, Peschken C. Clinical Features and Prognosis of Late -onset Systemic Lupus Erythematosus: Results from the 1000 Faces of Lupus Study. The Journal of Rheumatology 2010; 37(1): 38-44.

https://doi.org/10.3899/jrheum.080957

Batool S, Nighat MA, Saeed MA, Sumaira F. Pattern of initial clinical manifestations of systemic lupus erythematosus in a tertiary care hospital. Pak J Med Sci 2016; 32(5): 1066-1070.

http://doi.org/ 10.12669/pjms.325.11480

Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon n, et al. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken) 2012; 64(2): 159-168.

https://doi.org/10.1002/acr.20683

Barber MR, Drenkard C, Falasinnu T, Hoi A, Mak A, Know NY, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 2021; 17(9): 515-532.

https://doi.org/10.1038/s41584-021-00668-1

Domer T, Furie R. Novel paradigms in systemic lupus erythematosus. Lancet 2019; 393: 2344-2358.

Arnaud L, Tektonidou MG. Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors. Rheumatology 2020; 59: v29-v38.

https://doi.org/10.1093/rheumatology/keaa 382

Durcan L, O Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 2019; 393: 2332-2343.

Felten R, Sagez F, Gavand PE, . 10 most important contemporary challenges in the management of SLE. Lupus Sci Med 2019; 4: e000793.

Webb R, Kelly JA, Somers EC, Hughus T, Koufman KM, Sanchez E, et al. Early disease onset is predicted by a higher genetic risk of lupus and is associated with a more severe phenotype in lupus patients. Annual of the Rheumatic Disease 70(1), BMJ.

https://doi.org/10.1136/ard.2010.141697

Khan ZA, Mushtaq S, Sameena S, Salim B, Ahmed SN, Zahid et al. Clinico-Immunological Profile of Systemic Lupus Erythematosus Patients in Pakistan and Their Correlation. Pakistan Armed Forces Medical Journal, 72(4), 1181-1185.

https://doi.org/10.51253/pafmj. V72i4.6118

Frutos AR, Holgados S, Berge AS, Cases I, Olive A, Lopez-Longo FJ, et al. Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER). Rheumatology (Oxford) 2021; 60(4): 1793-1803.

https://doi.org/10.1093/rheumatology/keaa477

M A Rabbani, B K Siddiqui, and A Ahmad. Systemic lupus erythematosus in Pakistan. Sage Journals Oct 2004; 13(10): 266-269.

https://doi.org/10.1191/0961203303lu1077xx

Hou Y, Wang L, Lou C, Tang W, Dai R, An Y, et al. Clinical characteristics of early–onset paediatric systemic lupus erythematosus in a single centre in China. Rheumatology 2023; 62(10): 3373-3381.

https://doi.org/10.1093/ rheumatology/ kead086

Piraquire VO, Aristizabal IN, C CA, TGT, Mortality in Systemic lupus Erythematosus: causes predictors and interventions. Expert Rev Clin Immunol 2018; 14 (12): 1043-1053.

Anadi M, Amelio J, Bass D, Gairy K, Kauv G, Levy RA, Roth D. Systemic lupus Erythematosus, Lupus Nephritis, and end stage renal disease. A pragmatic Review mapping disease severity and proression. Lupus Jun 22, 2020; 29(9): 1011-1020.

https://doi.org/10.1177/0961203320932219

Norby GE, Mjoen G, Bjorneklett R, Vikse BE, Holdaas H, Svarstad E, et al. Outcome in biopsy-proven lupus nephritis: evaluation of biopsies from the Norwegian kidney biopsy registry. Lupus 2017; 26(8): 881–885.

Hanly JG, Urowitz MB, Su L. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2010; 69()3: 529-535.

Romero DJ, Garcia SI, Sanchez GJ. Thrombosis in systemic lupus erythematosus and other autoimmune disease of Recent onset. J Rheumatol 2009; 36(1): 68.

Bernardoff I, Picq A, Loiseau P, Foret T, Dufrost V, Moulinet T, et al. Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmun Rev 2022; 21(1): 102913.

https://doi.org/10.1016/j.autrev.2021.102913

Minerr JJ, Kim AH. Cardiac manifestation of systemic lupus erythematosus. Rheum Dis Clin North Am 2014; 40: 51.

Dein E, Douglas H, Petri M, Law G, Timlin H. Pericarditis in Lupus. Cureus 2019; 11(3): e4166.

https://doi.org/10.7759/ cureus.4166

Garcia AV, Castro SG, Isenberg DA. The diagnosis and management of the haematologic manifestations of lupus. J Autoimmun 2016: 74: 139-160.

https://doi.org/10.1016/j.jaut.2016.07.001

Santacruz JC, Mantilla MJ, Rueda I, Pulido S, Salas GR, Londono J, et al. A Practical Perspective of the Hematologic Manifestations of Systemic Lupus Erythematosus. Cureus 2022; 14(3): e22938.https://doi.org/10.7759/cureus.22938